SOLO LAB / ANALYTICAL DOCUMENTATION

Peptide Purity vs. Content: What Does a COA Percentage Mean?

A purity percentage, a quantity in milligrams, and a concentration describe different measurements. Understanding the reporting basis helps you read a Certificate of Analysis without treating one result as evidence for another.

Three measurements, three questions

MeasurementTypical reporting formQuestion answered
Chromatographic purityHPLC area %What share of the included detector response is assigned to the principal component?
Quantitative contentMass fraction, such as g/g or % by mass; or a measured amount on a defined basisHow much of the stated analyte was measured? Check whether “peptide” means total peptide material or the specific target compound.
ConcentrationMass per volume, such as mg/mL; or amount of substance per volume, such as mol/LHow much of the defined analyte is present per stated volume?

NIST’s archived RM 8327 report distinguishes peptide UV area purity from peptide mass purity. The BIPM SI Brochure separately identifies mass concentration and amount-of-substance concentration. Read the quantity name as well as its unit.

What HPLC area purity measures

A chromatographic run separates components and records detector responses over time. Area purity compares the integrated response assigned to the principal component with the included total response. The result belongs to those measurement conditions and that integration.

It is not a weighing of everything physically present in the material. Components that are not represented by the detector response cannot be accounted for by simply reading the main peak’s percentage. Different substances may also produce different responses. Method details therefore matter when interpreting an area result.

The NIST report’s separate area and mass measurements illustrate why the two percentages are not interchangeable. That report is archived: its historical reference values are not current specifications or results for Solo Lab products.

What does “peptide content” mean on this report?

Start with the laboratory’s definition. “Content” may refer to total peptide-derived material, the specific target compound, or an amount assigned to a particular preparation. These are different analytical claims.

For a target-compound mass fraction, the numerator is the target compound’s mass and the denominator is the mass of the material being characterized. A result reported on a dry basis need not have the same meaning as one reported for the material as received. Water, counterions, and other components may affect the mass being considered; do not assume their amounts or how the laboratory handled them.

NIST’s angiotensin I methods study examines several approaches to assigning peptide purity by mass fraction, including mass balance and impurity-corrected amino acid analysis. It concerns a characterized model material, not a universal conversion from HPLC area percentage.

Equal area purity can accompany different measured content

The reports would not be contradictory merely because their content differs. They answer different questions. The next useful question is how each quantitative result was obtained and what material basis it uses, rather than which single headline percentage looks larger.

Milligrams and concentration are different information

A milligram value states mass. A value in mg/mL states mass per volume. A value in mol/L states amount of substance per volume. The SI Brochure’s quantity and unit tables distinguish these kinds of quantities.

A catalog strength stated in mg does not, by itself, specify a concentration. Nor does the label alone establish that an independent content assay confirmed the stated quantity. Use the actual product description and applicable analytical record rather than adding an unstated volume or measurement.

This distinction also applies when comparing documents: an area percentage, a mass fraction, and a concentration cannot be ranked as if they were the same number.

How can content be measured, and what are the limits?

The method must fit the quantity being assigned. The FDA-published ICH Q2(R2) guideline treats assay and impurity measurements separately and discusses selectivity, calibration, accuracy, and precision. A method name alone does not establish all of these characteristics.

  • Amino acid analysis: amino-acid-derived content is not automatically a selective measurement of the target peptide. Other peptide or protein material can contribute amino acids. Target-specific assignment needs appropriate characterization and, where necessary, impurity correction.
  • Quantitative NMR: it can support a quantitative assignment using suitable signals and a defined reference. Interpretation still depends on which signals are measured, potential interference, and the measurement basis.
  • An assay against a characterized standard: a calibrated procedure can measure a defined analyte. Check what standard and reporting basis were used and whether the procedure distinguishes relevant interfering material.

The NIST angiotensin I study compares complementary mass-fraction approaches. A 2026 NIST protein-reference-material report, section 5, also explains the need to assess impurities that yield amino acids in quantitative amino acid analysis. That protein example supports the analytical limitation; it is not testing evidence for any Solo Lab peptide.

These are method concepts, not a claim that any of these analyses was performed on a catalog item. The applicable report must state the actual work and results.

To understand the supporting plots and identity evidence, compare HPLC chromatograms, mass spectra, and LC-MS reports.

What should I ask if content is missing?

If a COA reports area purity but no quantitative content, describe content as unreported in that document. Do not manufacture a result by multiplying the percentage by a labeled mg value.

  • What exactly does the laboratory mean by “peptide content”: total peptide material or the target compound?
  • Is the result a mass fraction, an amount per unit, or a concentration?
  • Is it reported for the material as received, on a dry basis, or on another defined basis?
  • Was content measured independently, and what method and reference supported it?
  • How were relevant impurities or interference addressed?
  • What limitations or measurement uncertainty should accompany the result?

Absent information is a reason to request the applicable record or clarification. It cannot be supplied by a different seller’s report or a publication about the molecule.

Read the measurement in its original context

Open the applicable Lab Results and identify the quantity, unit, and method actually reported. For a missing or unclear assay, ask Solo Lab about the specific product and lot.

For the broader document-review workflow, use How to read a peptide Certificate of Analysis. The Peptide Guide covers compound research context. Neither literature about a molecule nor a purity percentage establishes a research product’s suitability for human or animal use.

Sources and scope

Sources reviewed October 17, 2026. These references explain analytical concepts and reporting. They do not imply Solo Lab testing, accreditation, certification, or regulatory approval.

  1. NIST RM 8327 archived report (2007): distinct area-purity and mass-purity measurements. The archived values are not current product specifications.
  2. Josephs et al., angiotensin I purity mass-fraction methods study (2018), NIST publication record: complementary approaches, including impurity-corrected amino acid analysis and quantitative NMR.
  3. FDA / ICH Q2(R2), Validation of Analytical Procedures (March 2024): analytical purpose and procedure performance in its pharmaceutical-guidance context.
  4. BIPM SI Brochure, ninth edition: quantity names and concentration units.
  5. NIST SP 260-263, Certification of SRM 2921a Human Cardiac Troponin Complex (January 2026), section 5: impurities that contribute amino acids during quantitative analysis of a protein reference material.

QUICK ADD

Choose your options

Choose a product option and quantity. Checkout opens order review; it does not place an order or submit payment.

21+ · Research only. Not for human or animal consumption.

SOLO LAB PEPTIDES

BEFORE YOU ENTER

21+ RESEARCH ACCESS

You must be at least 21 years old. Products are exclusively for laboratory research and must not be consumed by or administered to humans or animals. Personal use, self-experimentation, medical and veterinary use are prohibited.

EXIT SITE

Research Use PolicyEligibility / 21+Privacy

This is age self-attestation, not identity verification. Acceptance is remembered for 30 days, or until the disclosures change. No date of birth is collected.